Normal | Controlled asthma | Uncontrolled asthma | |
All questions | 0.0 (0–0)* | 1.0 (0–1)* | 2.0 (2–3.5)* |
Nocturnal waking | 0.0 (0–0)* | 0.0 (0–1)* | 2.0 (1–2)* |
Morning symptoms | 0.0 (0–0)* | 1.0 (0–1)* | 2.0 (2–3)* |
Activity limitation | 0.0 (0–0)* | 0.5 (0–1)* | 1.5 (1–2)* |
Short of breath | 0.0 (0–0)* | 1.0 (1–1)* | 2.0 (2–3)* |
Wheeze | 0.0 (0–0)* | 1.0 (0.25–1)* | 2.0 (1.25–2.75)* |
FEV1 %pred | 0.0 (0–0)* | 1.0 (1–2)* | 4.0 (4–5)* |
β2-agonist alone | 0.0 (0–0)* | 1.0 (0.25–1)* | 3.5 (3–4)* |
Total and single item questionnaire data, presented as median (25th–75th centiles). There was a significant difference between the groups.
↵* p<0.001 for each single question and the total score.
FEV1, forced expiratory volume over 1 s.